2 Followers on Owler

Themis is a biopharmaceutical company that develops and commercializes immunomodulation therapies for the treatment of infectious diseases and cancer...

Read more

Themis is a biopharmaceutical company that develops and commercializes immunomodulation therapies for the treatment of infectious diseases and cancer...

Read more

Themis News

Themis Press Releases

Themis Headquarters

Muthgasse 11/2

Vienna, Vienna1190

43-1-236-7151

Driving Directions »

Themis Summary

ABOUT

Overview

Themis is a biopharmaceutical company that develops and commercializes immunomodulation therapies for the treatment of infectious diseases and cancer. Themis was founded in 2009. Themis' headquarters is located in Vienna, Vienna, AT 1190. Themis' Co-...

CEO

Themis's Co-Founder & CEO, Erich Tauber, currently has an approval rating of 88%. Themis's primary competitors are Spring Bank, MBC Pharma & Forma Therapeutics.

Acquisitions

There have been no acquisitions found related to Themis

Investments

Recent investment data cannot be found related to Themis

Frequently Asked Questions about Themis

  1. When was Themis founded?

    Themis was founded in 2009
  2. Who is Themis's CEO?

    Themis's CEO is Erich Tauber
  3. How much revenue does Themis generate?

    Themis generates $6.8M in revenue
  4. How much funding does Themis have?

    Themis has historically raised $73.7M in funding
  1. Where is Themis's headquarters?

    Themis's headquarters is in Vienna Vienna, AT
  2. How many employees does Themis have?

    Themis has 300 employees
  3. What sector does Themis operate in?

    Themis is in Biotechnology, Medical Research & Laboratories
  4. Who are Themis's competitors?

    Themis's top competitors are Spring Bank, MBC Pharma, Forma Therapeutics

Trending Companies